Total Funding
30
Total FundingSeed raised
Growth Score
pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Innovative Biologics is an anti-infective drug discovery and development company targeting microbes that produce pore-forming toxins.
About the Company
Innovative Biologics (IBI) is an anti-infective small molecule drug discovery and development company targeting microbes producing pore-forming toxins, such as MRSA and Hepatitis C. Many pathogens utilize the formation of pores in the membranes of target cells in the process of infection. IBI has developed the CycloPlex™ platform to identify
compounds which inhibit their action, based on blocking the target pore with molecules having the same symmetry as the pore itself, using ß-cyclodextrin as a scaffold.
